Clinical trial
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients: a Long-term Prospective Cohort Study
NCT02344680 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Liver Fibrosis in Zambian HIV-HBV Co-infected Patients: a Long-term Prospective Cohort Study
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- May 28, 2026
- Enrollment
- 349 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcoholic hepatitis, cirrhosis, liver, fibrosis, liver, hbv, hepatitis delta virus, hepatocellular carcinoma, human immunodeficiency virus